Rights and permissions
About this article
Cite this article
No adverse effect of Rx-to-OTC switch for H2RAs. Pharmacoecon. Outcomes News 475, 5 (2005). https://doi.org/10.2165/00151234-200504750-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504750-00007